Wednesday, February 1, 2023

Tag: sprout pharmaceuticals

Flibanserin’s ‘Effects’ Do Not Outweigh Harms, Review Finds

7
Despite concerns about the risk to benefit ratio, the FDA approved flibanserin (Addyi) to treat low female sexual desire in August. In a new...

“Doctors on Social Media Fail to Disclose Conflicts of Interest”

0
“A STAT examination of hundreds of social media accounts maintained by health-care professionals finds that while they often tweet medical advice, they almost never disclose potential conflicts of...